ALIONA
VIVS

Allianz Life Insurance of North America’s VivoSim Labs VIVS Stock Holding History

Allianz Life Insurance of North America’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-60
Closed -$203K – 136
2018
Q2 		$203K Buy
+60
New +$19.8K 0.24% 106

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Allianz Life Insurance of North America's VIVS Position: Q3 2018 in Review

Allianz Life Insurance of North America sold out of VivoSim Labs (VIVS) in Q3 2018, closing a stake of 60 shares — an estimated $203K sold.

Allianz Life Insurance of North America first reported a position in VIVS in Q2 2018 and held it in 1 quarter. The position peaked at $203K in Q2 2018. 116 funds tracked by Wall St. Rank hold VIVS as of Q3 2018.

  • Allianz Life Insurance of North America reported no remaining VivoSim Labs position as of Q3 2018 after selling out during the quarter.
  • Allianz Life Insurance of North America sold 60 VivoSim Labs shares in Q3 2018, an estimated $203K.
  • Allianz Life Insurance of North America first reported a position in VivoSim Labs in Q2 2018 and held it in 1 quarter.
  • Allianz Life Insurance of North America's VivoSim Labs position peaked at $203K in Q2 2018.
  • 116 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2018.

Based on Allianz Life Insurance of North America's 13F filing for Q3 2018, filed 16 Oct 2018.